Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesClinical update on teriparatide
Current Rheumatology Reports, 07/31/09
File E et al. – Teriparatide (recombinant human parathyroid hormone [1–34]) is an anabolic agent approved for the treatment of patients at high risk for fracture. Clinical trial data using antiresorptive agents administered before, during, and after any parathyroid hormone (PTH) therapy, as well as alternative PTH dosing, have provided additional insight yet raise fundamental questions about the most appropriate use of teriparatide. This article provides an update on teriparatide, focusing on its mechanism of action compared with other antiresorptive agents, indications, adverse effects, therapy duration, combination therapy, contraindications, and cost effectiveness.
Related Articles
Teriparatide Outperforms Alendronate In Treating Steroid-induced Osteoporosis
ScienceDaily, 10/30/09
Relevance Score: 87%
Successful treatment of sternal fracture nonunion with teriparatide
Osteoporosis International, 10/30/09
Relevance Score: 87%
Biomechanical effects of teriparatide in women with osteoporosis treated previously with alendronate and risedronate: Results from quantitative computed tomography-based finite element analysis of the vertebral body
Bone, 10/27/09
Relevance Score: 87%
Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Thirty-six-month results of a randomized, double-blind, controlled trial
Arthritis & Rheumatism, 11/03/09
Relevance Score: 84%
Teriparatide is safe and effectively increases bone biomarkers in institutionalized individuals with osteoporosis
Journal of Bone and Mineral Metabolism, 10/13/09
Relevance Score: 84%
Today in Bone Metabolism...keeping you current
Receive free subspecialty "5-minute updates" via email
Low Bone Mass and High Bone Turnover in Postmenopausal Human Immunodeficiency Virus-Infected Women
Journal of Clinical Endocrinology and Metabolism, 12/16/09
Pedometer determined ambulatory activity and bone mass: a population-based longitudinal study in older adults
Osteoporosis International, 12/16/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
A biodegradable antibiotic delivery system based on poly-for the treatment of osteomyelitis
Acta Orthopaedica, 12/16/09
Inadequate timing of prophylactic antibiotics in orthopedic surgery. We can do better
Acta Orthopaedica, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor